Frontlight ResearchEarly access
Coeliac disease trials in Finland
2 of 6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of ANB033
- Where
- Tampere
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- First Tracks Biotherapeutics Inc.
See details and how to join2024-520409-38-00 - Phase 2Taking peopleA study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet
- Where
- Helsinki, Jyväskylä, Oulu, Tampere, Turku
- Age
- 18 years and over
- People
- 461 worldwide
- Run by
- Dr. Falk Pharma GmbH
See details and how to join2023-506150-21-00